Browsing: Biotech

(Oct 23): The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.

(Oct 23): The Trump administration is seeking to restrict American investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.

Add preferred source The U.S. Treasury Department has added biotechnology as a new regulated sector under its proposed rules for the Comprehensive Outbound Investment National Security Act (COINS Act), moving to restrict equity investments and joint ventures in Chinese biotech companies. The scope covers pharmaceutical compounds, cell and gene therapies, gene sequencing, and lab automation.…

OpenAI has acquired Orchestra Bio, a four-year-old startup that develops artificial intelligence (AI) software for biotechnology companies, as the company expands its tools for life sciences research.

Despite an uptick in dealmaking and IPOs, a selective funding market and scientific setbacks are still pushing some biotechs to the brink.

The Conference That Wasn’t: A Fake Biotech Event Shows How Your Employees Might Let Ransomware In Th | Security, Privacy and the Law | Foley Hoag LLP

Dallas-based biotech startup MusiQ Bio, a UT Southwestern Medical Center spinoff, received a $2.59 million state grant to advance new cancer treatments.

Hakan Goker, managing director of M Ventures. Image C/O Optimum Strategic Communications.

A brand-new biotech startup with thousands of AI agents is sprouting at Stanford.

Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s led to a sudden spike in reverse merger deals.